Sonja Koestenbauer
Medical University of Graz
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sonja Koestenbauer.
American Journal of Obstetrics and Gynecology | 2010
Oleg V. Semenov; Sonja Koestenbauer; Mariluce Riegel; Nikolas Zech; Roland Zimmermann; Andreas H. Zisch; Antoine Malek
OBJECTIVE This study was undertaken to isolate and characterize multipotent mesenchymal stem cells from term human placenta (placenta-derived mesenchymal stem cells, PD-MSCs). STUDY DESIGN Sequential enzymatic digestion was used to isolate PD-MSCs in which trypsin removes the trophoblast layer, followed by collagenase treatment of remaining placental tissue. Karyotype, phenotype, growth kinetics, and differentiability of PD-MSC isolates from collagenase digests were analyzed. RESULTS PD-MSC isolation was successful in 14 of 17 cases. Karyotyping of PD-MSC isolates from deliveries with a male fetus revealed that these cells are of maternal origin. Flow cytometry and immunocytochemistry confirmed the mesenchymal stem cell phenotype. Proliferation rates of PD-MSCs remained constantly high up to passage 20. These cells could be differentiated toward mesodermal lineage in vitro up to passage 20. Nonconfluent culture was critical to maintain the MSC stemness during long-term culture. CONCLUSION Term placenta constitutes a rich, very reliable source of maternal mesenchymal stem cells that remain differentiable, even at high passage numbers.
American Journal of Reproductive Immunology | 2006
Sonja Koestenbauer; Nicolas H. Zech; Herbert Juch; Pierre Vanderzwalmen; Luc Schoonjans; Gottfried Dohr
The derivation of murine embryonic stem (mES) cell lines was reported for the first time in 1981 (Nature, 1981; 292:154–156; Proc Natl Acad Sci U S A, 1981; 78:7634–7638), and they have since proved to be a very useful tool with which to study mammalian development, which is characterized by pluripotency and differentiation. About 20 years later, the successful generation of human embryonic stem (hES) cell lines was described (Science, 1998; 282:1145–1147). Although mES and hES are derived from mammals, they cannot be looked at as being one and the same. While basic information for hES can be derived from mES, such information does not correspond on a one‐to‐one basis. This review gives an overview of the characteristics of embryonic stem cells with the main focus on the similarities and differences between human and mES cells.
Cell Transplantation | 2009
Sonja Koestenbauer; Andreas H. Zisch; Gottfried Dohr; Nicolas H. Zech
The reconstitution of adult stem cells may be a promising source for the regeneration of damaged tissues and for the reconstitution of organ dysfunction. However, there are two major limitations to the use of such cells: they are rare, and only a few types exist that can easily be isolated without harming the patient. The best studied and most widely used stem cells are of the hematopoietic lineage. Pioneering work on hematopoietic stem cell (HSC) transplantation was done in the early 1970s by ED. Thomas and colleagues. Since then HSCs have been used in allogenic and autologous transplantation settings to reconstitute blood formation after high-dose chemotherapy for various blood disorders. The cells can be easily harvested from donors, but the cell number is limited, especially when the HSCs originate from umbilical cord blood (UCB). It would be desirable to set up an ex vivo strategy to expand HSCs in order to overcome the cell dose limit, whereby the expansion would favor cell proliferation over cell differentiation. This review provides an overview of the various existing HSC expansion strategies—focusing particularly on stem cells derived from UCB—of the parameters that might affect the outcome, and of the difficulties that may occur when trying to expand such cells.
Journal of Heart and Lung Transplantation | 2010
Sonja Koestenbauer; Philipp Stiegler; Vanessa Stadlbauer; Ursula Mayrhauser; Bettina Leber; Martin Schweiger; Andrae Wasler; Günther Prenner; Michael Sereinigg; Sieglinde Zelzer; Tatjana Stojakovic; Michael Scarpatetti; Antonia Griesbacher; Joachim Greilberger; Karlheinz Tscheliessnigg
BACKGROUND After heart transplantation (HTx), endomyocardial biopsy (EMB) is currently the standard method to diagnose acute graft rejection. A non-invasive marker of rejection would be desirable as an alternative or to permit more selective use of the costly and invasive EMB. METHODS In this retrospective study, outcomes of routinely taken EMBs were used to select 28 patients after HTx EMB Grade 0R (8 patients), 1R (9 patients) or 2R (11 patients). For these patients, myeloperoxidase (MPO) and carbonyl proteins (CP) in serum were measured using enzyme-linked immunoassay (ELISA). RESULTS MPO and CP levels in post-HTx patients with Grade 2R rejection were significantly (MPO: p < 0.01; CP: p < 0.001) elevated at the time of rejection compared with levels 1 month earlier. MPO and CP levels predicted Grade 2R rejection and the best cut-off point was 237.5 μg/l for MPO and 222.5 pmol/mg for CP, respectively. Clinically most important was the marked increase (doubling of basic values within 1 month) of MPO and CP levels in cases of Grade 2R rejection in post-HTx patients. CONCLUSIONS MPO and CP seem to be appropriate parameters to monitor rejection events non-invasively and to minimize the application of EMBs after HTx.
Reproductive Biomedicine Online | 2005
Nicolas H. Zech; Sonja Koestenbauer; Pierre Vanderzwalmen; Luc Schoonjans; S. Danloy; Herbert Zech; A Blaschitz; Gottfried Dohr
One of the big question marks in current stem cell research is whether there is true plasticity of adult progenitor cells (APC) or if cell fusion is the principle source of the supposed plasticity. The generation of chimeras by injecting adult progenitor cells into blastocysts is not new. This paper describes an efficient embedding technique for murine blastocysts injected with human APC. This method could help in establishing a novel tool to analyse the process of plasticity, if it truly exists. If this is the case, this technology could be of great help to characterize surface markers of stem cells in great detail. On the other hand, fusion of cells could also be investigated. A system of embedding blastocysts was set up using paraffin for further analysis by means of light microscopy and immunohistochemistry. The embedding of the chimaeras consists of fixing them first with paraformaldehyde in phosphate-buffered saline (PFA/PBS), embedding them in gelatine, fixing the gelatine block with PFA/PBS and finally fixing the gelatine block in a Petri dish by embedding it in paraffin. Using this protocol, the morphology of the blastocysts is well preserved.
Annals of Biomedical Engineering | 2011
David P. O’Neill; Tingying Peng; Philipp Stiegler; Ursula Mayrhauser; Sonja Koestenbauer; Karlheinz Tscheliessnigg; Stephen J. Payne
Anticancer Research | 2011
Ursula Mayrhauser; Philipp Stiegler; Vanessa Stadlbauer; Sonja Koestenbauer; Bettina Leber; Katja Konrad; F. Iberer; Rupert H. Portugaller; Karlheinz Tscheliessnigg
Anticancer Research | 2012
Bettina Leber; Ursula Mayrhauser; Barbara Leopold; Sonja Koestenbauer; Karlheinz Tscheliessnigg; Vanessa Stadlbauer; Philipp Stiegler
Anticancer Research | 2011
Ursula Mayrhauser; Philipp Stiegler; Vanessa Stadlbauer; Sonja Koestenbauer; Bettina Leber; Katja Konrad; F. Iberer; Karlheinz Tscheliessnigg
Open Journal of Organ Transplant Surgery | 2012
Philipp Stiegler; Ursula Mayrhauser; Sonja Koestenbauer; Bettina Leber; Katja Konrad; F. Iberer; Karlheinz Tscheliessnigg; Vanessa Stadlbauer